Official UK procurement notice
Supply of Additive Solutions for the Suspension of Blood Products
Authority: NHS Blood and Transplant (Central government)
What is being bought
Published requirement descriptionNHSBT uses Platelet Additive Solution (PAS) for the suspension and storage of pooled platelets, and Saline Adenine Glucose Mannitol (SAGM) solution in the manufacture and storage of washed red cells.<br/><br/>The framework agreement was awarded to MacoParma after an OJEU open tender exercise on behalf of selected beneficiaries (blood services from the UK, Ireland, Australia and New Zealand).
CPV: Blood-transfusion supplies
The lotProcurement structure
single lot · no lot value publishedLot #1This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and…
This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the Authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.<br/><br/>Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 21 Dec 2022, 11:03 GMT
- Last source update
- 21 Dec 2022, 11:03 GMT
- Authority reference
C27251 (NHSBT1075)- FTS notice number
2022/S 000-036161- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-039338Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This Framework Agreement was let for a period of 4-years starting on 01/12/2018, and expired on 30/11/2022. Due to circumstances outside of the Authority's control, including dealing with the impact of Covid-19 and a related procurement exercise being delayed, the Authority wishes to extend this Framework Agreement by 1-Year. This extension will allow the authority adequate time to complete the related procurement exercise, and allow sufficient time to carry out the required validation exercise for the retendering of this requirement.<br/><br/>Therefore, this VEAT notice will cover the period 1 December 2022 to 30 November 2023.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 036161-2022-1
- Signed
- 1 Dec 2022
- Value
- £464,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- The High CourtReview body
Framework contractors & participating bidders
1 commercial party on the notice- MacoPharma UK LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.